Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: Role of mitochondrial adenosine triphosphate-dependent potassium channels

Journal of Thoracic and Cardiovascular Surgery

Volumn 124, Issue 4, 2002, Pages 750-757

  Loubani, Mahmoud ^a   Galiñanes, Manuel ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5 HYDROXYDECANOIC ACID; ANISOMYCIN; DIAZOXIDE; INDICATOR; NICORANDIL; PHENYLEPHRINE; PHORBOL 13 ACETATE 12 MYRISTATE; POTASSIUM CHANNEL; PRAZOSIN; PROTEIN KINASE C;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART ATRIUM MUSCLE; HEART MITOCHONDRION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HUMAN TISSUE; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

EID: 0036818949     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.126037     Document Type: Article

References (24)

1. Krumenacker M, Roland EO. Clinical profile of nicorandil: An overview of its haemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol. 1992;20:S93-102.
2. Frampton J, Buckley M, Fitton A. Nicorandil: A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs. 1992;44:625-55.
3. ATP channel in unstable angina. Eur Heart J. 1999;20:51-7.
4. Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988;9:21-8.
5. Flaherty JT. Nitrate tolerance: A review of the evidence. Drugs. 1989;37:523-50.
6. Suryapranata H, MacLeod D. Nicorandil and cardiovascular performance in patients with coronary artery disease. J Cardiovasc Pharmacol. 1992;20:S45-51.
7. Hiraoka M, Fan Z. Activation of ATP-sensitive outward potassium current by nicorandil (2-nicotinamidoethyl-nitrate) in isolated ventricular myocytes. J Pharmacol Exp Ther. 1989;250:278-85.
8. + channel? Circ Res. 1995;77:1030-5.
9. Ghosh S, Standen N, Galiñanes. Evidence for mitochondrial channels as effectors of human myocardial preconditioning. Cardiovasc Res. 2000;45:934-40.
10. Ghosh S, Standen N, Galiñanes M. Preconditioning the human myocardium by simulated ischemia: Studies on the early and delayed protection. Cardiovasc Res. 2000;45:339-50.
11. Pain T, Yang X, Critz SD, et al. Opening of mitochondrial KATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;87:460-6.
12. Holmuhamedov EL, Jovanovic S, Dzeja PP, Jovanovic A, Terzic A. Mitochondrial ATP-sensitive K+ channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol. 1998;275:H1567-76.
13. Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, Marban E. Mitochondrial ATP-dependent potassium channels. Viable candidate effectors of ischemic preconditioning. Ann N Y Acad Sci. 1999;874:27-37.
14. Imagawa J, Baxter GF, Yellon DM. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol. 1998;31:74-9.
15. Carr CS, Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol. 1997;92:25-260.
16. Zhang JG, Ghosh S, Ockelford C, Galiñanes M. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man. Clin Sci. 2000;99:339-50.
17. Nishikawa Y, Kanki H, Ogawa S. Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilatation in human coronary circulation. J Cardiovasc Pharmacol. 1998;32:21-8.
18. ATP channels are upstream of PKC and p38MAPK activation in the preconditioning of the human myocardium by alpha 1 adrenoceptors [abstract]. Eur Heart J. 2001;22:384.
19. Naito A, Aniya Y, Sakanashi M. Antioxidative action of nitrovasodilator nicorandil: Inhibition of oxidative activation of liver microsomal glutathione S-transferase and lipid peroxidation. Jpn J Pharmacol. 1994;65:209-13.
20. Matata BM, Galiñanes M. Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: Regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg. 2000;120:1-11.
21. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103:1863-8.
22. Nagueh SF, Stetson SJ, Lakkis NM, et al. Decreased expression of tumor necrosis factor-alpha and regression of hypertropic after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001;103:1844-50.
23. Ferdinandy P, Danial H, Ambrus I, Rothery RA, Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res. 2000;87:241-7.
24. Ghosh S, Standen NB, Galiñanes M. Failure to precondition pathological human myocardium. J Am Coll Cardiol. 2001;37:711-8.